Navigation Links
GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference
Date:7/30/2010

LOUISVILLE, Colo., July 30 /PRNewswire/ -- One of the biggest challenges faced by healthcare providers today is gaining control of the purchase of physician preference items (PPI), such as orthopedic implants, cardiac stents, pacemakers and other advanced medical devices, which can be among the most expensive items that hospitals buy. GHX will present strategies for optimizing procurement processes, especially around PPI, at the AHRMM 2010 Annual Conference & Exhibition, to be held Aug. 1-4 in Denver.

To highlight practical applications of effective PPI management within a provider organization, Dale Locklair, vice president, procurement and construction, McLeod Health, will lead in-booth discussions at Booth #401 on Monday, Aug. 2. An area in which procurement optimization can have a big impact is in the ordering of products for the operating room (OR)—specifically, high-cost implantables. In his presentations, Locklair will discuss how McLeod Health has saved more than $2 million in just six months since implementing new procedures in the OR. Locklair will present the sessions, entitled "Creating a Supply Chain Without Walls," at 2 p.m. and 3 p.m. MDT. No registration is necessary.

Physician preference items frequently account for as much as 40 percent of a hospital system's medical-surgical supply spend, according to Datamonitor, a provider of global business information. Many of those items are not in a hospital's enterprise resource planning (ERP) or materials management information system (MMIS), which makes them difficult to manage. PPI purchases, meanwhile, are estimated to be growing at a compounded average rate of 17 percent, compared to less than 3 percent for commodity items like sutures and gloves.

GHX has also published a new white paper, entitled "Procurement Optimization: A Holistic Approach," which provides a perspective on employing more effective procurement strategies in today's challenging healthcare environment. The white paper provides additional guidance on how to use technology, people and processes to address these challenges. Topics include:

  • Why procurement optimization is important
  • How physician preference item purchases affect the bottom line
  • The five main challenges of procurement optimization
  • How creating a tighter linkage between the revenue cycle and supply chain can lead to real, measurable benefits
  • Four steps to achieve an optimal procurement function

To download a copy of the white paper, go to http://www.ghx.com/tabid/918/Default.aspx, or visit the GHX Booth, #401, at the AHRMM conference.

Procurement processes can also be enhanced through broader adoption and use of industry supply chain standards. GHX will also conduct in-booth sessions on how healthcare organizations can prepare for the pending sunrise dates by which group purchasing organizations and others in the market have called for use of the GS1 standards for location and product identification. The sessions, entitled, "Getting Ready for Sunrise," will be held Tuesday, Aug. 3, at 10 a.m. and 11 a.m. MDT in the GHX booth. Ed McCauley, GHX vice president and general manager, e-sourcing and business intelligence, will discuss best practices developed as a result of numerous pilots conducted by GHX and its participating trading partners to enable the use of standards in supply chain transactions.  

About GHX

As the business hub for healthcare, Global Healthcare Exchange, LLC (GHX) enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making.  Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B. Braun Medical Inc.; BD; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc.  For more information, visit www.ghx.com.


'/>"/>
SOURCE GHX
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Menopause Drugs Price Analysis and Strategies - 2016, provides drug ... answers the following questions: What are the ... positioned in the Global Menopause market? What are the ...
Breaking Medicine Technology:
(Date:2/23/2017)... Boston, MA (PRWEB) , ... February 23, 2017 ... ... Education and Department of Justice jointly issued a letter to withdraw ... in accordance with their gender identity. The guidance issued in May 2016 by ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association ... Annual Meeting. KLS is a longtime supporter of the event. , "We are ... Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a global data and ... Premier Research, a leading clinical development service provider, has selected ERT’s Trial Oversight ... due in part to an array of circumstances including the use of multiple ...
(Date:2/23/2017)... ... (PRWEB) February ... for the nation to come together to combine its favorite ... with its favorite fruit – apples! To celebrate National Nutrition ... join the “Apple Madness” bracket tournament – a five-week, five-round ...
Breaking Medicine News(10 mins):